and French TechBio startup Cure51 announced that Cure51 will deploy 10x Genomics’ Visium HD as part of its pioneering work to ...

Genomics is innovating in spatial technologies but faces hurdles. Discover why TXG stock’s price/cashflow ratio and ...

10x tools comprise three platforms: the original Chromium platform for analyzing loose single cells, which contributes the bulk of company revenue; the Visium platform for spatial analysis of ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select ...

10x Genomics' talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents and software that analyze biological systems at a resolution that ...

The Visium CytAssist is a compact, benchtop instrument that enables the transfer of transcriptomic probes from standard glass slides to Visium slides, enabling spatial profiling insights to be gained ...